Back to Journals » ImmunoTargets and Therapy

ImmunoTargets and Therapy

COPE logo
ISSN: 2253-1556

Journal Image

Editor-in-Chief: Professor Michael R Shurin

ImmunoTargets and Therapy is an international journal that aims to present and publish basic and clinical research on the aspects of immunology in health and disease. ImmunoTargets and Therapy is primarily focused on the immunological basis of disease and explores the evidence behind new and existing immunotherapies in terms of improving outcomes and, importantly, will seek to define their usage in terms of ultimate uptake and acceptance by the patient and health care professional.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE). 


This journal offers Accelerated Publication.

 

Latest articles:

- 5 records -

T Helper Cells and Cytokine Networks in the Immunopathogenesis of Multiple Sclerosis

Egba SI, Ikechukwu GC, Okereke CI, Orhonigbe IO, Uroko RI, Ugwu OPC

ImmunoTargets and Therapy 2026, 15:607713

Published Date: 25 June 2026

Irinotecan Modulates Immune Checkpoints in Neuroblastoma

Lapidus T, Zorde-Khvalevsky E, Jolani A, Goldstein G, Peled A

ImmunoTargets and Therapy 2026, 15:598469

Published Date: 12 June 2026

Myeloid Cell-Derived Thrombospondin-1 Mediates Anti-Metastatic Effects of Histamine Dihydrochloride in B16 Melanoma

Issdisai N, Kaya M, Hellstrand K, Grauers Wiktorin H, Martner A

ImmunoTargets and Therapy 2026, 15:596703

Published Date: 6 June 2026


Read more articles